Recently, α6 integrin has been proposed as the epithelial cell receptor for papillomavirus. This study investigated whether α6 integrin is the cellular receptor for bovine papillomavirus type 4 (BPV-4), which is strictly epitheliotropic and infects the mucous epithelium of the upper digestive tract. Primary bovine mucosal keratinocytes from the palate of a foetus (PalK) displayed high levels of α6 integrin ; matched primary fibroblasts from the same biopsy (PalF) expressed almost no α6 integrin. However, BPV-4 bound both PalK and PalF to similar, saturable levels. Native BPV-4 virions infected PalK in vitro, as detected by RT-PCR of E7 RNA. Infection could be blocked by excess virus-like particles (VLPs) and by neutralizing antisera against L1-L2 and L1 VLPs or by denaturation of the virions, supporting the view that infection in vitro mimics the process in vivo. α6 integrin-negative human keratinocyte cell lines were derived from patients affected by junctional epidermolysis bullosa presenting genetic lesions in their hemidesmosomes. The level of α6 integrin expression was determined in these cell lines by in situ immunofluorescence and FACS. Despite the absence of α6 integrin expression by BO-SV cells, they were bound by BPV-4 to similar, saturable levels as normal keratinocytes, KH-SV. Furthermore, BO-SV and KH-SV cells were both infected by BPV-4 to apparently the same extent as PalK cells. These results are consistent with the conclusion that α6 integrin is not the obligatory receptor for a bovine mucosotropic papillomavirus.
Introduction
Papillomaviruses are the aetiological infectious agents of a number of cancers (Beutner & Tyring, 1997 ; Campo, 1997 ; Zur Hausen & Rosl, 1994) . Many are exquisitely epitheliotropic, but the basis of this cell specificity is not understood (de Villiers, 1998 ; Lowy & Schiller, 1998) . Not much is known about the initial step of infection, but it is believed to be docking of the virus with a receptor on the host-cell surface. Whilst papillomavirus tropism may be due in part to the requirements of the virus for transcription and replication, cell specificity may also be conferred by the cellular receptor. Virus receptors are extremely diverse, including sialyloligosaccharides for influenza virus (Suzuki, 1997) , ICAM-1 for rhinoviruses (Ohrui et al., 1996) , glycosaminoglycan chains of VLPs can lack conformational epitopes (Chen et al., 1998) , and conversely morphologically normal virions presenting conformational epitopes can be non-infectious (P. O'Brien, personal communication) .
Although most papillomaviruses are extremely tissue and species specific, it has been proposed that the papillomavirus receptor is widely expressed, as both virions and VLPs bind to a variety of cell lines (Muller et al., 1995 ; Qi et al., 1996) . Bovine papillomavirus type 1 (BPV-1) is not strictly epitheliotropic : it infects both epidermal keratinocytes and dermal fibroblasts in vivo giving rise to fibropapillomas (Campo, 1987) and it infects and transforms murine fibroblast C127 cells in vitro. The infection in vitro can be blocked by competition with VLPs of the strictly epitheliotropic human papillomavirus type 16 (HPV-16), indicating that the two viruses share the same receptor (Roden et al., 1994) . Recently, however, using VLPs for HPV-6b, a candidate receptor has been proposed, the integrin α6 partnered by either β1 or β4 integrin (Evander et al., 1997) .
In the skin and mucosae, integrin α6 exclusively binds to integrin β4 to form an heterodimeric cell receptor critical for hemidesmosome formation and cell adhesion. Genetic mutations affecting expression of integrin α6β4 result in junctional epidermolysis bullosa with pyloric atresia (PA-JEB), a severe genodermatosis characterized by extensive epithelial disadhesion (Vidal et al., 1995 ; Ruzzi et al., 1997) .
By using bovine epithelial cells and PA-JEB keratinocytes, we have investigated whether α6 integrin is the cellular receptor for the strictly epitheliotropic papillomavirus BPV-4. Our results suggest strongly that α6 integrin is not the obligatory receptor for BPV-4.
Methods
Cells and cell lines. Primary PalK and PalF cells were derived from foetal bovine oral palate and grown as described previously (Sibbet et al., 1995) . SV40-immortalized human keratinocyte lines were derived from a healthy control (KH-SV cells) and from patients with PA-JEB carrying a homozygous mutation in the integrin α6 gene (BO-SV cells). These cell lines were immortalized by using infectious SV40 virions as described previously (Miquel et al., 1996) and were maintained in keratinocyte growth medium (Clonetics\BioWhittaker) supplemented with bovine pituitary extract in the presence of 0n09 mM Ca# + .
Monoclonal antibodies.
The following rat monoclonal antibodies were used for both in situ immunofluorescence and FACS analysis as primary antibodies : GoH3, anti-CD49f, specific for α6 integrin, and 439-9B, anti-CD104, specific for β4 integrin (PharMingen) (Kennel et al., 1989 ; Sonnenberg et al., 1987) . The secondary antibody was FITCconjugated anti-rat IgG (whole molecule) (Sigma).
In situ immunofluorescence. Cells were plated at 1n2i10$ per well and grown in 0n4 ml lots on 8-well glass chamber slides (Labtek). Cells were washed with PBS and then fixed with formaldehyde (3n7%) and permeabilized (0n5 % Triton X-100) and the nuclei were counterstained with 1 µg\ml propidium iodide. Primary antibodies were typically used at 10-100-fold dilution and secondary FITC-labelled antibodies were used 75-fold diluted. Cells were well washed (PBS plus 0n025 % Tween 80) prior to mounting with Vectashield (Vector Labs).
FACS analysis. Cells were detached, washed on ice and resuspended at 4i10' cells\ml. Aliquots (50 µl) of cells were placed in roundbottomed 96-well plates on ice and treated with the relevant monoclonal antibodies. After excess primary and secondary antibodies had been washed off, cells were fixed overnight with formaldehyde (3n7 %) and analysed by FACS the following day. The number of fluorescent cells was plotted against the level of fluorescence on a log scale. The background levels of fluorescence (secondary antibody alone) were subtracted before determining the levels of integrins on the cell surface. The net levels of fluorescence for each cell line were plotted in a bar chart.
BPV-4 virus binding.
The concentration of virions was determined by electron microscopy (Gaukroger et al., 1996) . Cells were plated at 5i10& per 3 cm dish in 2 ml medium. BPV-4 virus was added at an estimated 100 virus particles per cell and allowed to bind for up to 2 h at 4 or 37 mC. After extensive washing in DMEM and PBS, cells with bound virus were drained and harvested in 250 µl ProtK mix (0n1 mg\ml proteinase K, 50 mM KCl, 0n5 % NP40, 0n5 % Tween). Cell protein was digested for over 2 h at 56 mC and then for 15 min at 95 mC to inactivate the proteinase K. Viral DNA was detected by PCR. To quantify virus binding, aliquots of cell lysate or cell culture medium supernatant were subjected to PCR in a volume of 50 µl with a 5 min 95 mC hot start and 30 rounds of amplification, annealing at 60 mC (Perkin Elmer Taq polymerase and reagents). Amplified products were separated on 1n2% agarose gels and stained with ethidium bromide. Bands were quantified by image capture by using the Bio-Rad GelDoc 1000 system followed by scanning with the Bio-Rad Molecular Analyst (version 1.5) software. These conditions enabled quantification of PCR products within a linear range of almost two orders of magnitude, as determined by serial dilution of template prior to PCR.
BPV-4 virus ' infection '.
Cells were plated at 5i10' and allowed to grow to 10( cells per T175 flask, and infected with purified BPV-4 virions at an estimated number of virus particles per cell of 50-100. Infected cells were extensively washed and harvested and RNA was extracted (RNAzol) at early time-points and up to 7 days after infection (Chomczynski & Sacchi, 1987) . Residual DNA was removed by RNasefree DNase I digestion followed by purification on SNAP columns (Invitrogen). Viral RNA was detected by reverse transcription (RT) followed by two rounds of PCR, as described below.
PCR and primer pairs. Primers for actin were derived from the sequence of bovine actin-1 cDNA : 5h ATCCAGGCTGTGCTGTCTCT 3h (nt 178-197) and 3h ATCTCCTGCTCGAAGTCCAA 5h (nt 433-452). Primers for bovine myc were derived by sequence comparison of mouse, cat and human c-myc sequences and correspond to bases 1020-1037 and 1288-1307 of the human sequence : 5h AAGCAGATCAGCAACAAC 3h and 3h TTGTGTTTCAACTGTTCTCG 5h. The BPV-4 outer primer pair was 5h TGAGGCAGTAGCTCTCAT (nt 313-330) and 3h TAT-AACCCGTCAAGAGCCCC 5h (nt 3957-3976). The BPV-4 inner primer pair was 5h GCTGACCTTCCAGTCTTAAT 3h (nt 642-661) and 3h TGAAGAGGAGATTGAAACTG 5h (nt 793-812). These primers amplify a 170 bp fragment from RNA transcribed from the E7 ORF.
RT-PCR.
The method was derived from the Perkin Elmer RNA PCR core kit. Typically, 1-2 µg RNA was reverse-transcribed after annealing to oligo(dT) for 10 min at room temperature by reverse transcription at 42 mC for 60 min followed by 5 min in boiling water to denature the RT activity. The composition of the RT reaction mixture was then adjusted to suit Taq polymerase and two rounds of PCR were performed : 5 µl of the first PCR was used as the template for the second PCR. Both BPV-4 DCI α6 integrin is not the receptor for BPV-4 α6 integrin is not the receptor for BPV-4 outer and inner primer pairs went through 30 rounds of amplification, with a 95 mC hot start and annealing at 60 mC. Contamination with DNA was avoided by RNase-free DNase I digestion and purification by SNAP columns (Invitrogen). Control reactions lacking RT were always included.
Results

BPV-4 binding to keratinocytes and fibroblasts
BPV-4, unlike BPV-1, is highly mucosotropic and infects only the keratinocytes of the upper gastrointestinal tract. To examine whether the virus tropism was conferred by binding to specific cell surface receptors, we have derived matched primary keratinocytes (PalK) and fibroblasts (PalF) from the same biopsy of bovine foetal palate tissue. PalK and PalF cells were plated out in monolayer culture in DMEM and were examined by immunofluorescence for expression of the candidate papillomavirus receptor, α6 integrin. Only PalK cells expressed α6 integrin ; PalF cells expressed almost no α6 integrin, as judged by the binding of GoH3 antibody (Fig.  1 a) . This agrees with the published pattern of α6 integrin expression in tissue sections, where normal fibroblasts do not express α6 integrin ; its expression becomes activated upon cell immortalization and transformation (Aplin et al., 1996 ; Terpe et al., 1994) . To test whether the distribution of the putative receptor reflects virus binding to these cells, PalF and PalK cells were plated out in subconfluent monolayers, in 3 cm dishes as for the immunofluorescence studies, and incubated with more than 10( purified infectious BPV-4 virions derived from a palate papilloma. Virions were tested for infectivity by inoculating the palate of a cow (Chandrachud et al., 1995) . Despite the differential expression of α6 integrin, the extent of specific, saturable virion binding to PalK and PalF cells was very similar over a 2 h time-course (Fig. 1 b) .
BPV-4 infection of keratinocytes
The advantage of using virions rather than VLPs to determine the specificity of virus binding and uptake is that infection can be detected by assaying for transcription of the viral genes. However, as BPV-4 transcription is cell specific, being approximately 40-fold more active in PalK cells than in PalF cells (Morgan et al., 1999) , only PalK cells were used for BPV-4 infection experiments.
PalK cells were plated and infected with purified BPV-4 virions at a high ratio of virus particles per cell. Infected cells were harvested and RNA was extracted at early time-points and up to 7 days after infection. RNA samples were digested with DNase I and purified. An RT-PCR protocol was developed to detect viral transcripts. Oligo(dT) was used to generate cDNA from the RNA and two rounds of PCR with nested primers specific for the viral E7 sequences were used to amplify BPV-4 transcripts. To exclude the possibility of contamination by viral DNA in the PCR step, controls included no RT and, to exclude non-specific uptake of virus, denatured virions were used in parallel. Fig. 2 (a) shows that a specific viral transcript could be detected within 2 h of infection and remained for up to 7 days. The PCR product was sequenced and was confirmed to be E7. The same preparations of cDNA were amplified by one round of PCR with actin primers or c-myc primers (Fig. 2 c) , showing that PCR amplification of cellular RNA was simply dependent upon RT and was unaffected by the presence or absence of infectious or denatured virus.
To test the specificity of virus infection of PalK cells further, before infection in vitro, virus was pre-incubated with various immune sera from cattle vaccinated with either L1-L2 VLP (F267), L1 VLP (F274) or L2 (F259), or competed for with excess BPV-4 VLP (Chandrachud et al., 1995 ; Kirnbauer et al., 1996) (Fig. 2 b) . Pre-immune serum had no effect on virus infectivity but immune sera F267 and F274 both blocked infection, as judged by the absence of a PCR product, as did VLP competition. Pre-incubation with L2 immune serum F259 (Fig. 2 b) or with an anti-L2 hyperimmune serum (not shown ; O'Brien et al., 1999) did not block infection and a PCR product was generated. This agrees with our previous vaccination results, which showed that anti-L1 antisera prevent infection while anti-L2 antisera prevent disease but not infection (Gaukroger et al., 1996) .
The candidate receptor is not required for virus binding or infection of keratinocytes
We have shown that the candidate receptor, α6 integrin, is highly expressed in PalK cells and absent from PalF cells, but that BPV-4 binds equally to both cell types. As we cannot monitor BPV-4 transcription in PalF cells, in order to examine the role of α6 integrin in infection, we required cells in which BPV-4 DNA could be efficiently transcribed but which lacked the candidate receptor. We derived a keratinocyte cell line from a patient with a genetic lesion in the α6 integrin gene (BO-SV) (Gache et al., 1998 ; Ruzzi et al., 1997) . The level of α6β4 integrin expression was determined in this cell line by in situ immunofluorescence and FACS analysis and compared with the cell line KH-SV (normal human keratinocytes immortalized with SV40 large T antigen) and primary keratinocytes. Fig. 3 (a) shows the immunofluorescence of KH-SV cells and BO-SV cells decorated by monoclonal antibodies GoH3 and CD49e, specific for α6 and β4 integrins, respectively (Sonnenberg et al., 1987) . Both antibodies were derived from rat and were visualized with FITC-labelled anti-rat secondary antibody. The GoH3-staining pattern of KH-SV cells was very similar to that of PalK cells, although it was less extensive. The punctate distribution of β4 was also similar. In contrast, BO-SV cells showed negligible α6 integrin immunofluorescence, while the punctate β4 staining was very weak. Levels of fluorescence were normalized between cell lines by counter-staining the cell nuclei with propidium iodide (Fig. 3 a) . The overall distribution of integrins over the cell surface was also quantified by FACS analysis by using the primary and secondary antibodies described above, and the results confirmed the in situ immunofluorescence results. The BO-SV cell line displayed extremely low levels of α6 integrin, while β4 integrin was much reduced compared with normal KH-SV cells (Fig. 4) .
To assess whether the distribution of candidate virus receptor on KH-SV and BO-SV keratinocyte cell lines determines the level of binding of BPV-4 virus, the virusbinding experiments already described for PalK and PalF cells were employed. Despite the lack of α6 integrin on the surface of BO-SV cells, the time-course of saturable binding of virus was essentially equivalent in the two cell lines (Fig. 3 b) .
Furthermore, having validated the in vitro infection of PalK cells (Fig. 2) , we infected the BO-SV cells with BPV-4 exactly as before. After RT-PCR of KH-SV and BO-SV RNA, the same RT-dependent E7 amplicon of 170 bp was detected (Fig. 3 c) .
Despite the presence of a very weak band in the kRT lanes, which may represent a residual trace of viral DNA resistant to DNase I digestion, the experiment shows clearly that both cell lines had internalized and transcribed the viral genome, independently of the amount of α6 or β4 integrin displayed on the cell surface. 
Discussion
The answer to the question of how papillomaviruses infect their host cells and the identity of the receptor have, until recently, proved elusive. The productive life-cycle of most papillomaviruses is exquisitely dependent on keratinocyte cell type and cellular differentiation. As the first step in keratinocyte differentiation is for cell division to cease when cells move into the suprabasal compartment, studying papillomavirus infection in regular cell culture has proved extremely difficult. Virus can be recovered from papillomas but, apart from BPV-1 and to a lesser extent BPV-4, the yield of virus is usually poor. This is particularly true for those epitheliotropic papillomaviruses with a role in cancer (HPV-16, HPV-18) . Similarly, only very small quantities of papillomavirus have been produced in vitro and these depend on difficult techniques such as raft or organotypic culture, or infecting epithelial ' chips ' and passaging them through immuno-compromised mice. The development of VLPs by Zhou et al. (1992) enabled the study of binding of papillomavirus to cells. By expressing the late genes in eukaryotic or prokaryotic systems, it has been shown that L1 alone can self-assemble into VLPs that apparently bind cells specifically. Because of the absence of a good assay for infection, questions remain about the specificity of the binding and whether it is the same as that of normal virions. It has been observed that some batches of purified virus display correct epitopes but are not infectious (P. O'Brien, personal communication), and the same could be true of VLPs. Normal viruses are required to test the issue of specificity. BPV-4, like HPV-16, infects mucosal epithelium and is tumorigenic, but, unlike HPV-16, it is produced at higher levels and can readily be recovered from oral papillomas, overcoming the potential drawbacks of VLPs. As well as the ability to test virions for infectivity in the host animals, the advantages over VLPs in the study of candidate receptors are that viral genomic DNA can be detected by PCR and that viral gene expression can be distinguished by RT-PCR. We therefore chose to investigate the interaction of BPV-4 with its target cells by using virions rather than VLPs.
By using HPV-6 L1 VLPs, it has recently been suggested that α6 integrin is a candidate cell receptor for papillomavirus (Evander et al., 1997) . However, we found that the presence of the candidate receptor is not required for BPV-4 binding, as both primary keratinocytes (which express α6 integrin) and primary fibroblasts (which do not) bind virion equally well. Likewise, human keratinocytes that do not express α6 integrin (BO-SV) bind virus to the same extent as wild-type keratinocytes (KH-SV).
Virion binding to the cell surface is one of the first steps of infection, followed by internalization, uncoating and transport of the viral genome into the nucleus (or, less often, retention in the cytoplasm for some viruses), where transcription of the viral genes takes place.
As binding of virions to the receptor is not necessarily followed by internalization, and a secondary receptor may be needed for this step (Broder & Dimitrov, 1996 ; Montgomery et al., 1996 ; Whitbeck et al., 1997 ; Wu et al., 1996) , it is possible that α6 integrin could act as a secondary receptor and mediate papillomavirus internalization rather than binding. We therefore used transcription of the viral E7 gene as a measure of efficient virus internalization. We developed an RT-PCR assay for E7 transcripts in PalK cells ; this assay proved to be very informative. The E7 amplicon was detected in PalK cells 2 h after infection and for up to 7 days, showing that infection had taken place and established itself. The amplicon was also detected when infection took place in the presence of preimmune serum, but was not detected in the presence of competing VLPs or of virus-neutralizing anti-L1 antisera (Kirnbauer et al., 1996) . However, the E7 transcript was still detected in the presence of anti-L2 antisera. This is in total agreement with our results obtained in vivo showing that anti-L1 antibodies block infection whereas anti-L2 antibodies prevent disease but not infection (Gaukroger et al., 1996) . Although we did not detect spliced mRNA within the timeframe of these experiments (Smith et al., 1993 ; White et al., 1998) , the competition with VLPs and the neutralization of virus by the immune sera show that our RT-PCR assay is robust enough to reflect genuine infection in its early stages. As infection in vitro is abortive and does not proceed, it is likely that only pre-mRNA is made and that mature spliced forms are not produced. We next applied the assay to keratinocytes defective in α6 integrin expression (Gache et al., 1998 ; Ruzzi et al., 1997) and, consistent with the virion-binding studies, we detected the E7 amplicon independently of the presence of α6 integrin on the cell surface. This shows that bovine and human keratinocytes are infected equally well by BPV-4, that they share the same receptor and that this receptor is not α6 integrin. We therefore conclude that α6 integrin is not an obligatory receptor for BPV-4.
This conclusion does not imply that α6 integrin is not a papillomavirus receptor, and does not preclude the possibility that α6 integrin could be closely associated with another cell surface molecule that acts as a receptor. The recent finding that the expression of α6 integrin confers papillomavirus binding to receptor-negative DG75 cells (McMillan et al., 1999) may be explained by α6 integrin inducing or stabilizing a receptor such as α-dystroglycan, which is closely associated with integrins, binds laminin and can be localized along the basement membrane (Cao et al., 1998 ; Henry & Campbell, 1998) .
Our investigation into the binding and infection of cells by a bovine papillomavirus does not preclude the possibility that BPV-4 and HPV-6 use different receptors. Whilst this would seem unlikely, given that BPV-1 and HPV-16 VLPs can compete for binding to the same cell (Roden et al., 1994) , more than one receptor may well exist. Such diverse receptors could be used by the virus in different situations both in vivo and under experimental conditions. After all, BPV-1 infection forms fibropapillomas in cattle and thus infects both dermal keratinocytes, which express α6 integrin, the candidate receptor, and fibroblasts, which do not. The nature of the cell receptor used by BPV-4 to infect keratinocytes remains to be elucidated.
